Type 2 Diabetes

Compounds, known as conjugated linoleic acids (CLA), have also shown promising results in human trials, signaling a new way of potentially treating diabetes without synthetic drugs.

Researchers find changes to protein SirT1 can prevent excess metabolic stress associated with obesity, diabetes and aging.

Increasing the concentration of a key regulator involved in glucose metabolism can improve the way the liver produces and disposes of the sugar glucose.

Researchers have discovered a potential new target for treating type 2 diabetes. The target is a protein, along with its molecular partner, that regulates fat metabolism.

As significant a problem as obesity is among the general population, it's an even greater problem for adults with disabling conditions.

Diet of low-fat products is better than smaller portions of normal high-fat food for preventing diabetes in obese people.

Researchers at the Joslin Diabetes Center have shown that an enzyme found in the mitochondria of cells is decreased in the skeletal muscle of those with diabetes, a finding that could lead to the development of drugs to boost the activity of this enzyme in an effort to fight the disease.

An estimated 39,000 U.S. adolescents may have type 2 diabetes and more than 2.5 million may have impaired fasting glucose levels, which could lead to diabetes and other health problems.

Patients with Type 2 diabetes and periodontal disease who receive periodontal therapy see levels of oxidative stress, a condition in which antioxidant levels are lower than normal, reduced to the same levels as nondiabetic patients.

Find out how much the use of insulin among patients with type 2 diabetes and out-of-pocket expenditures per prescription have increased.

A study in the journal Sleep shows that frequent napping is associated with an elevated prevalence of type 2 diabetes and impaired fasting glucose.

A research team led from Uppsala University has seen links between high levels of perfluorinated compounds in the blood and diabetes.

Most oral medications prescribed for type 2 diabetes are similarly effective for reducing blood glucose, but the drug metformin is less likely to cause weight gain and may be more likely than other treatments to decrease so-called bad cholesterol. The new study directly compared 10 oral medications.

A new study has found that PPARã can turn genes both on and off. Knowing how to turn a gene off may permit researchers to develop drugs that would decrease TZD-related side effects such as weight gain and edema.

Being even moderately physically fit lowers a diabetic man's risk of death, regardless of his weight, according to a new study.

Elevated blood levels of two inflammatory substances seem to be independent risk factors for type 2 diabetes, researchers report.